Boston, MA, based Investment company Cormorant Asset Management, LLC (Current Portfolio) buys Arcturus Therapeutics Holdings Inc, Pliant Therapeutics Inc, BioNTech SE, Repare Therapeutics Inc, Akouos Inc, sells Constellation Pharmaceuticals Inc, Principia Biopharma Inc, Mirati Therapeutics Inc, Acceleron Pharma Inc, CRISPR Therapeutics AG during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Cormorant Asset Management, LLC. As of 2020Q2, Cormorant Asset Management, LLC owns 77 stocks with a total value of $2.4 billion. These are the details of the buys and sells.

For the details of Cormorant Asset Management, LLC's stock buys and sells,
go to www.gurufocus.com/guru/cormorant+asset+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Cormorant Asset Management, LLC

  1. Turning Point Therapeutics Inc (TPTX) - 2,737,297 shares, 7.39% of the total portfolio. Shares reduced by 10.45%
  2. SPDR S&P500 ETF TR (SPY) - 500,000 shares, 6.44% of the total portfolio.
  3. ChemoCentryx Inc (CCXI) - 1,700,000 shares, 4.09% of the total portfolio. Shares reduced by 16.05%
  4. Principia Biopharma Inc (PRNB) - 1,590,493 shares, 3.97% of the total portfolio. Shares reduced by 24.26%
  5. BridgeBio Pharma Inc (BBIO) - 2,590,762 shares, 3.53% of the total portfolio. Shares reduced by 12.18%

New Purchase: Pliant Therapeutics Inc (PLRX)

Cormorant Asset Management, LLC initiated holding in Pliant Therapeutics Inc. The purchase prices were between $21.3 and $35.26, with an estimated average price of $26.54. The stock is now traded at around $24.92. The impact to a portfolio due to this purchase was 0.79%. The holding were 611,409 shares as of .

New Purchase: BioNTech SE (BNTX)

Cormorant Asset Management, LLC initiated holding in BioNTech SE. The purchase prices were between $38.58 and $66.74, with an estimated average price of $50.01. The stock is now traded at around $67.70. The impact to a portfolio due to this purchase was 0.49%. The holding were 175,000 shares as of .

New Purchase: Repare Therapeutics Inc (RPTX)

Cormorant Asset Management, LLC initiated holding in Repare Therapeutics Inc. The purchase prices were between $30.8 and $32.99, with an estimated average price of $32.1. The stock is now traded at around $25.36. The impact to a portfolio due to this purchase was 0.46%. The holding were 352,795 shares as of .

New Purchase: Akouos Inc (AKUS)

Cormorant Asset Management, LLC initiated holding in Akouos Inc. The purchase prices were between $22 and $22.5, with an estimated average price of $22.29. The stock is now traded at around $20.84. The impact to a portfolio due to this purchase was 0.45%. The holding were 499,990 shares as of .

New Purchase: Kadmon Holdings Inc (KDMN)

Cormorant Asset Management, LLC initiated holding in Kadmon Holdings Inc. The purchase prices were between $3.7 and $5.26, with an estimated average price of $4.48. The stock is now traded at around $4.33. The impact to a portfolio due to this purchase was 0.39%. The holding were 1,800,000 shares as of .

New Purchase: AVEO Pharmaceuticals Inc (AVEO)

Cormorant Asset Management, LLC initiated holding in AVEO Pharmaceuticals Inc. The purchase prices were between $3.47 and $9.99, with an estimated average price of $6.28. The stock is now traded at around $5.04. The impact to a portfolio due to this purchase was 0.29%. The holding were 1,350,000 shares as of .

Added: Arcturus Therapeutics Holdings Inc (ARCT)

Cormorant Asset Management, LLC added to a holding in Arcturus Therapeutics Holdings Inc by 205.30%. The purchase prices were between $12.66 and $58.27, with an estimated average price of $34.22. The stock is now traded at around $53.93. The impact to a portfolio due to this purchase was 1.05%. The holding were 800,000 shares as of .

Added: Sorrento Therapeutics Inc (SRNE)

Cormorant Asset Management, LLC added to a holding in Sorrento Therapeutics Inc by 30.00%. The purchase prices were between $1.73 and $6.76, with an estimated average price of $3.8. The stock is now traded at around $12.37. The impact to a portfolio due to this purchase was 0.39%. The holding were 6,500,000 shares as of .

Added: uniQure NV (QURE)

Cormorant Asset Management, LLC added to a holding in uniQure NV by 77.66%. The purchase prices were between $45.06 and $67.74, with an estimated average price of $58.84. The stock is now traded at around $40.63. The impact to a portfolio due to this purchase was 0.37%. The holding were 444,157 shares as of .

Added: Insmed Inc (INSM)

Cormorant Asset Management, LLC added to a holding in Insmed Inc by 24.22%. The purchase prices were between $14.11 and $29.42, with an estimated average price of $23.54. The stock is now traded at around $27.67. The impact to a portfolio due to this purchase was 0.1%. The holding were 450,000 shares as of .

Added: Gossamer Bio Inc (GOSS)

Cormorant Asset Management, LLC added to a holding in Gossamer Bio Inc by 76.09%. The purchase prices were between $9.52 and $15.98, with an estimated average price of $12.52. The stock is now traded at around $14.07. The impact to a portfolio due to this purchase was 0.08%. The holding were 349,325 shares as of .

Sold Out: Constellation Pharmaceuticals Inc (CNST)

Cormorant Asset Management, LLC sold out a holding in Constellation Pharmaceuticals Inc. The sale prices were between $28.63 and $49.79, with an estimated average price of $35.94.

Sold Out: Neurocrine Biosciences Inc (NBIX)

Cormorant Asset Management, LLC sold out a holding in Neurocrine Biosciences Inc. The sale prices were between $85.09 and $130.36, with an estimated average price of $110.15.

Here is the complete portfolio of Cormorant Asset Management, LLC. Also check out:

1. Cormorant Asset Management, LLC's Undervalued Stocks
2. Cormorant Asset Management, LLC's Top Growth Companies, and
3. Cormorant Asset Management, LLC's High Yield stocks
4. Stocks that Cormorant Asset Management, LLC keeps buying



Source link